Reflecting on Thirty Years of Progress with Dr. Larry Norton
37m
·
Investigating Breast Cancer
·
Since Evelyn H. Lauder and Dr. Larry Norton launched BCRF in 1993 remarkable advances in breast cancer prevention, diagnosis, treatment, survivorship, and metastasis have been made. But there is still critical work to be done.The Foundation is moving faster and closer than ever to achieving its mission to prevent and cure breast cancer by advancing the world’s most promising research.
We spoke with BCRF co-founder and Founding Scientific Director, Dr. Larry Norton to discuss the progress BCRF has made and what advances are on the horizon. Dr. Norton is Senior Vice President in the Office of the President and Medical Director of the Evelyn H. Lauder Breast Center at Memorial Sloan Kettering Cancer Center. He is also a Professor of Medicine, Weill-Cornell Medical College.Dr. Norton has dedicated his life to the eradication of cancer through his work in medical care, laboratory and clinical research, advocacy, and government.
The episode Reflecting on Thirty Years of Progress with Dr. Larry Norton from the podcast Investigating Breast Cancer has a duration of
37:57. It was first published
More episodes from Investigating Breast Cancer
Improving Treatments for Invasive Lobular Carcinoma with Dr. Adrian Lee
In the latest episode of Investigating Breast Cancer, Dr. Adrian Lee discusses collaboration, strategies to improve treatment for ILC, and more. A BCRF investigator since 2013, he is the Pittsburgh Foundation chair and director of the Institute for Precision Medicine at the University of Pittsburgh and UPMC
Improving Breast Cancer Radiation Treatments with Dr. Rachel Jimenez
In the latest episode, Dr. Rachel Jimenez discusses a new strategy of delivering radiation called proton beam radiation that could reduce treatment time and minimize its damaging effects on the heart. Unlike traditional radiation, proton therapy radiation can target cancer cells specifically, sparing other healthy tissues from potential damage.
Dr. Jimenez is an assistant professor of radiation oncology at Harvard Medical School and the chair for quality and safety in the department of radiation oncology at Massachusetts General Hospital.
The Effects of a High-Fiber Diet in Early-Stage Breast Cancer with Dr. Laura Esserman
Dr. Laura Esserman talks about her current research that examines how fiber shapes the gut microbiome, potentially improving the response to immune agents in women newly diagnosed with breast cancer.
Her prior research looked at how immune cells in tumors influence tumor response to immune drugs, and she believes the gut microbiome plays a key role in this complex system.
A BCRF investigator since 1998, Dr. Esserman is an internationally recognized breast surgeon, breast oncology specialist, and personalized medicine visionary.
BCRF 2023 New York City Symposium
In October, BCRF holds its annual New York Symposium and Awards Luncheon. The event recognizes BCRF-supported investigators for their devotion to ending breast cancer and announces the Foundation’s research investment for the coming year.
In this special episode of Investigating Breast Cancer, you’ll hear this year’s extraordinary symposium, co-moderated by BCRF Founding Scientific Director Dr. Larry Norton and BCRF Scientific Director Dr. Judy Garber, that included Drs. Seema Khan, Constance D. Lehman, and Olufunmilayo I. Olopade.
Investigating Novel Biomarkers for Personalized Treatments with Dr. Roisin Connolly
Breast cancer is a profoundly personal disease, and blanket approaches may not work for all patients. In fact, some can avoid particular therapies or treatments altogether. BCRF investigators have played a significant role in developing precision medicine and individualized therapies, improving treatment efficacy and limiting side effects.
This is the area where Dr. Roisin Connolly’s work is centered. In this latest episode Dr. Connolly discusses her work to uncover more personalized treatments for breast cancer patients with triple-negative breast cancer. A BCRF investigator since 2022, Dr. Connolly is the Director and Professor Gerald O’Sullivan Chair in cancer research at University of College Cork and Cork University Hospital in Ireland.